- Genetic data will be safeguarded with 23andMe sale, drugmaker vows The Washington Post
- Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million WSJ
- Why Regeneron is buying 23andMe Endpoints News
- Struggling DNA testing firm 23andMe to be bought for $256m BBC
- Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale GlobeNewswire